Rexahn Pharmaceuticals, Inc. To Present At The 16th Annual Rodman & Renshaw Global Investment Conference On September 9, 2014

ROCKVILLE, Md.--(BUSINESS WIRE)--Rexahn Pharmaceuticals, Inc. (NYSE MKT: RNN), a clinical stage biopharmaceutical company developing best-in-class therapeutics for the treatment of cancer, today announced that Peter D. Suzdak, PhD, the Company’s Chief Executive Officer, will present at the 16th Annual Rodman & Renshaw Global Investment Conference, sponsored by H.C. Wainwright & Co, LLC. The presentation will be on Tuesday, September 9th at 12:05 PM EDT. The presentation will be webcast live. To access the webcast, please visit http://wsw.com/webcast/rrshq24/rnn. The conference is being held September 8-10, 2014, at The Palace Hotel in New York City.

Hey, check out all the research scientist jobs. Post your resume today!